Clinical Trial Update: Chemothetapy FORFIRINOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating FOLFIRINOX chemotherapy in advanced or recurrent extrahepatic cholangiocarcinoma and gallbladder carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma of the Extrahepatic Bile Duct
• Gallbladder Cancer

Drugs mentioned

• FOLFIRINOX

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer | Phase 2 | Status: UNKNOWN